Business Context and Reporting Period
This Form 6-K filing by Evaxion A/S covers the month of October 2025, with the report dated October 17, 2025. The filing primarily details corporate actions regarding share capital increases and amendments to the Articles of Association resulting from an at-the-market (ATM) offering and the exercise of investor warrants.
Key Financial Metrics and Capital Activity
- ATM Offering Proceeds: Sold 1,018,000 ADSs at an average price of $4.3931 per ADS, generating approximately $4.3 million in net proceeds after fees and expenses.
- Warrant Exercise Proceeds: Received aggregate cash consideration of DKK 10,344,064.35 (approximately $1.61 million USD) from October 3 to October 10, 2025.
- Share Capital Increase: Total nominal share capital increased from DKK 91,682,151.50 to DKK 99,048,464 following the ATM offering and warrant exercises.
- Revenue and Profit: The filing text does not provide a clear value for revenue, profit, cash flow, margins, or debt levels.
Material Changes Versus Prior Period
The filing does not provide comparative financial data against a prior period. The material changes reported are strictly structural and capital-related:
- Issuance of 1,018,000 ADSs in September 2025.
- Issuance of 29,465,250 ordinary shares between October 3 and October 10, 2025, via warrant exercises.
- Amendments to the Articles of Association to reflect these capital increases.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors beyond the standard disclosure of the capital transactions. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the exact number of outstanding shares post-issuance to assess dilution impact.
- Confirm the current cash balance and burn rate, as this filing only reports inflows from capital raises.
- Review the remaining capacity under the Capital Demand Sales Agreement with Jones Trading Institutional Services LLC.
- Check for any subsequent filings regarding the utilization of the raised capital.